Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23722)

• Formulation Name: Doxorubicin Hydrochloride 20mg/10ml liposomaldispersion
• Company: Baxter Healthcare Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Doxorubicin	(DMVP5YE)	Solid tumour/cancer	2A00-2F9Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonium sulfate	(E00490)	6097028	Buffering agent
Cholesterol	(E00092)	5997	Emollient; Emulsifying agent
Histidine	(E00106)	6274	Antioxidant; Buffering agent
Hydrochloric acid	(E00015)	313	Acidulant
N-(carbonyl-methoxypolyethylene glycol 2000)-1	(E00685)	86278269	Other agent
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Soybean lecithin	(E00637)	Not Available	Other agent